Upgrade to SI Premium - Free Trial

Teva Pharma (TEVA) PT Slashed to $10 at Cantor Fitzgerald

November 2, 2017 1:39 PM
Cantor Fitzgerald analyst Louise Chen lowered her price target on Teva Pharma (NYSE: TEVA) to $10.00 (from $17.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles